Evidence map›Paper›PMID 24795641›Full record

ReviewFrontiers in physiology2014

Multidrug resistance in fungi: regulation of transporter-encoding gene expression.

Sanjoy Paul, W Scott Moye-Rowley

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 139 citations in OpenAlex.

  1. Article
  2. Microbiology spectrum · 2025
    Article
  3. Article
  4. Inhibitory Effect and Mechanism of Dryocrassin ABBA AgainstInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Role of ERG11 and MDR1 genes in cycloheximide and multidrug resistance in Candida species.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  8. Blap-6, a Novel Antifungal Peptide from the Chinese Medicinal BeetleInternational journal of molecular sciences · 2024
    Article
  9. Article
  10. Frontiers in cellular and infection microbiology · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Molecular dissection studies ofFrontiers in microbiology · 2023
    Article
  16. A novel ZnCurrent genetics · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sanjoy PaulDepartment of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa Iowa City, IA, USA.
W Scott Moye-RowleyDepartment of Molecular Physiology and Biophysics, Carver College of Medicine, University of Iowa Iowa City, IA, USA.
University of Iowa · US

Funding

GENETIC ANALYSIS OF PLEIOTROPIC DRUG RESISTANCER01GM049825 · NIGMS · UNIVERSITY OF IOWA · PI MOYE-ROWLEY, W SCOTT · 1993 to 2019
$6.0M
Role of transcriptional regulation in Aspergillus fumigatus drug resistanceR21AI092331 · NIAID · UNIVERSITY OF IOWA · PI MOYE-ROWLEY, W SCOTT · 2011 to 2012
$415k
NIAID NIH HHS R21 AI092331NIGMS NIH HHS R01 GM049825
6 · The paper itself

Abstract

A critical risk to the continued success of antifungal chemotherapy is the acquisition of resistance; a risk exacerbated by the few classes of effective antifungal drugs. Predictably, as the use of these drugs increases in the clinic, more resistant organisms can be isolated from patients. A particularly problematic form of drug resistance that routinely emerges in the major fungal pathogens is known as multidrug resistance. Multidrug resistance refers to the simultaneous acquisition of tolerance to a range of drugs via a limited or even single genetic change. This review will focus on recent progress in understanding pathways of multidrug resistance in fungi including those of most medical relevance. Analyses of multidrug resistance in Saccharomyces cerevisiae have provided the most detailed outline of multidrug resistance in a eukaryotic microorganism. Multidrug resistant isolates of S. cerevisiae typically result from changes in the activity of a pair of related transcription factors that in turn elicit overproduction of several target genes. Chief among these is the ATP-binding cassette (ABC)-encoding gene PDR5. Interestingly, in the medically important Candida species, very similar pathways are involved in acquisition of multidrug resistance. In both C. albicans and C. glabrata, changes in the activity of transcriptional activator proteins elicits overproduction of a protein closely related to S. cerevisiae Pdr5 called Cdr1. The major filamentous fungal pathogen, Aspergillus fumigatus, was previously thought to acquire resistance to azole compounds (the principal antifungal drug class) via alterations in the azole drug target-encoding gene cyp51A. More recent data indicate that pathways in addition to changes in the cyp51A gene are important determinants in A. fumigatus azole resistance. We will discuss findings that suggest azole resistance in A. fumigatus and Candida species may share more mechanistic similarities than previously thought.

Indexed as

ABC transportersfungal pathogensmultidrug resistanceregulation of gene expressiontranscriptiontranscription factors

Identifiers

PMID24795641
PMCPMC3997011
OpenAlexW2051876017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.